Divi's Laboratories (NSE:DIVISLAB) Other Long-Term Liabilities : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories Other Long-Term Liabilities?

Divi's Laboratories's other long-term liabilities for the quarter that ended in Dec. 2023 was ₹0 Mil.

Divi's Laboratories's quarterly other long-term liabilities increased from Jun. 2023 (₹0 Mil) to Sep. 2023 (₹5,930 Mil) but then declined from Sep. 2023 (₹5,930 Mil) to Dec. 2023 (₹0 Mil).

Divi's Laboratories's annual other long-term liabilities increased from Mar. 2021 (₹3,381 Mil) to Mar. 2022 (₹4,214 Mil) and increased from Mar. 2022 (₹4,214 Mil) to Mar. 2023 (₹5,372 Mil).

Divi's Laboratories Other Long-Term Liabilities Historical Data

The historical data trend for Divi's Laboratories's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Divi's Laboratories Other Long-Term Liabilities Chart

Divi's Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Divi's Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Divi's Laboratories Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Divi's Laboratories Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Divi's Laboratories's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Divi's Laboratories (NSE:DIVISLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (NSE:DIVISLAB) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

532488:India

Address

Divi Towers, 1-72/23(P)/DIVIS/303, Babukhan Lane, Cyber Hills, Gachibowli, Hyderabad, TG, IND, 500032

Website

https://www.divislabs.com

Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. Most of the company's sales are generated in Europe, followed by North America, India, and Asia. The company has three distinct business segments: Generic APIs, Custom Synthesis, and Nutraceuticals. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Divi's Laboratories (NSE:DIVISLAB) Headlines

No Headlines